Capacity Bio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
2ndary - Private
- Investors
-
4
Capacity Bio General Information
Description
Developer of a mitophagy therapeutic platform intended to improve mitochondrial quality and function in disease research and drug development. The company offers small molecules, peptides, nanoparticles, and analytical tools for identifying dysfunctional mitochondria, activating mitophagy pathways, and measuring mitochondrial characteristics, enabling biotechnology researchers and drug developers working on neurodegenerative, autoimmune, muscular, and genetic orphan indications to study mitochondrial biology and advance preclinical therapeutic programs.
Contact Information
Website
www.capacitybio.comCorporate Office
- 570 Westwood Plaza
- Building 114
- Los Angeles, CA 90095
- United States
Corporate Office
- 570 Westwood Plaza
- Building 114
- Los Angeles, CA 90095
- United States
Capacity Bio Timeline
Capacity Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | Completed | Pre-Clinical Trials | ||||
| 3. Accelerator/Incubator | 01-Nov-2023 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC | 31-Mar-2023 | $35M | $54.2M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 17-Jan-2023 | $19.2M | $19.2M | Completed | Pre-Clinical Trials |
Capacity Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-2 | ||||||||
| Seed-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Capacity Bio Comparisons
Industry
Financing
Details
Capacity Bio Competitors (3)
One of Capacity Bio’s 3 competitors is Mighty Therapeutics, a Private Equity-Backed company based in Needham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mighty Therapeutics | Private Equity-Backed | Needham, MA | ||||
| Acurex Biosciences | Venture Capital-Backed | San Carlos, CA | ||||
| Mitochon Pharmaceuticals | Venture Capital-Backed | Blue Bell, PA |
Capacity Bio Patents
Capacity Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026041086-A1 | Mas agonists and processes of making thereof | Pending | 22-Aug-2024 | ||
| AU-2022212113-A1 | Methods and agents that stimulate mitochondrial turnover for treating disease | Pending | 28-Jan-2021 | ||
| CA-3209749-A1 | Methods and agents that stimulate mitochondrial turnover for treating disease | Pending | 28-Jan-2021 | ||
| EP-4284779-A1 | Methods and agents that stimulate mitochondrial turnover for treating disease | Pending | 28-Jan-2021 | ||
| EP-4284779-A4 | Methods and agents that stimulate mitochondrial turnover for treating disease | Pending | 28-Jan-2021 | A61K31/4178 |
Capacity Bio Signals
Capacity Bio Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Magnify | Accelerator/Incubator | |||
| AN Venture Partners | Venture Capital | Minority | ||
| RA Capital Management | Asset Manager | Minority | ||
| Remiges Ventures | Venture Capital | Minority |
Capacity Bio FAQs
-
When was Capacity Bio founded?
Capacity Bio was founded in 2021.
-
Where is Capacity Bio headquartered?
Capacity Bio is headquartered in Los Angeles, CA.
-
What is the size of Capacity Bio?
Capacity Bio has 10 total employees.
-
What industry is Capacity Bio in?
Capacity Bio’s primary industry is Drug Discovery.
-
Is Capacity Bio a private or public company?
Capacity Bio is a Private company.
-
What is Capacity Bio’s current revenue?
The current revenue for Capacity Bio is .
-
How much funding has Capacity Bio raised over time?
Capacity Bio has raised $54.2M.
-
Who are Capacity Bio’s investors?
Magnify, AN Venture Partners, RA Capital Management, and Remiges Ventures have invested in Capacity Bio.
-
Who are Capacity Bio’s competitors?
Mighty Therapeutics, Acurex Biosciences, and Mitochon Pharmaceuticals are competitors of Capacity Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process